NeuroPace (NPCE) Inventory (2020 - 2026)

NeuroPace has reported Inventory for 7 years, with the latest figure at $16.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 22.93% year-over-year to $16.7 million; the trailing twelve-month figure through Mar 2026 stood at $16.7 million (up 22.93% YoY), and the FY2025 full-year result was $16.9 million, up 26.27% from the prior year.
• Inventory for Q1 2026 stood at $16.7 million, down from $16.9 million in the prior quarter.
• The five-year high for Inventory was $18.1 million in Q3 2025, with the low at $8.1 million in Q1 2022.
• Average Inventory over 5 years is $12.1 million, with a median of $11.4 million recorded in 2024.
• Year-over-year, Inventory increased 6.2% in 2024 and surged 50.07% in 2025.
• Tracing NPCE's Inventory over 5 years: stood at $9.7 million in 2022, then advanced by 15.47% to $11.2 million in 2023, then rose by 19.32% to $13.4 million in 2024, then climbed by 26.27% to $16.9 million in 2025, then slipped by 1.2% to $16.7 million in 2026.
• The last three Inventory figures came in at $16.7 million (Q1 2026), $16.9 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison